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2ABSTRACT
The metabolic fate, toxicity and effects on endogenous metabolism of paracetamol 
(acetaminophen, APAP) in 22 female Landrace cross large white pigs were evaluated in a 
model of acute liver failure (ALF). Anaesthetized pigs were initially dosed at 250 mg/kg via 
an oroduodenal tube with APAP serum concentrations maintained above 300 mg/L using 
maintenance doses of 0.5-4g/h until ALF. Studies were undertaken to determine both the 
metabolic fate of APAP and its effects on the endogenous metabolic phenotype of ALF in 
using 1H NMR spectroscopy. Increased concentrations of citrate combined with pre-ALF 
increases in circulating lactate, pyruvate and alanine in plasma suggest mitochondrial 
dysfunction and a switch in hepatic energy metabolism to glycolysis in response to APAP 
treatment. A specific liquid chromatography-tandem mass spectrometry assay was used to 
quantify APAP and metabolites. The major circulating and urinary metabolite of APAP was 
the phenolic glucuronide (APAP-G), followed by p-aminophenol glucuronide (PAP-G) 
formed from N-deacetylated APAP. The PAP produced by N-deacetylation was the likely 
cause of the methaemoglobinemia and kidney toxicity observed in this, and previous, studies 
in the pig. The phenolic sulfate of APAP, and the glutathione-derived metabolites of the drug 
were only found as minor components (with the cysteinyl conjugate detected but not the 
mercapturate). Given its low sulfation, combined with significant capacity for N-
deacetylation the pig may represent a poor translational model for toxicology studies for 
compounds undergoing significant metabolism by sulfation, or which contain amide bonds 
which when hydrolysed to unmask an aniline lead to toxicity.  However, the pig may provide 
a useful model where extensive amide hydrolysis is seen for drugs or environmental 
chemicals in humans, but not in e.g., the rat and dog which are the pre-clinical species 
normally employed for safety assessment. 
Keywords: Paracetamol/acetaminophen, metabolism, metabonomics, metabolomics, liver, 
kidney. 
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3Overdose of the analgesic drug Paracetamol (acetaminophen, 4-hydroxyacetanalide, APAP) 
is a well-known cause of drug induced liver injury (DILI). As such APAP is a leading cause 
of acute liver failure (ALF), which is associated with high mortality and orthotopic liver 
transplantation (Lee 2012).  A porcine model of ALF has previously been shown to provide a 
reproducible and clinically relevant model of paracetamol-induced hepatotoxicity (Baker et 
al. 2015; Lee et al. 2015; Lee et al. 2013) and has been used to test the “University College 
London Liver Dialysis Device (UCL-LDD)” currently being developed as a treatment for 
ALF. Previous studies with the model showed that chronic APAP dosing for up to 20 hours 
led to ALF onset (Lee et al. 2013). In humans, and most preclinical species, APAP 
metabolism occurs primarily in the liver. The major biotransformations involve conjugation 
to form the phenolic glucuronide (around 50%) and sulfate conjugates (30-40%) 
(Mazaleuskaya et al. 2015) although in rat the major metabolite is the sulfate  (McGill et al. 
2012). With increasing dose the formation of the sulfate plateaus, and oxidative metabolism 
mediated by cytochrome P450 increases, leading to the formation of the toxic reactive 
intermediate N-acetyl-p-benzoquinoneimine (NAPQI). NAPQI is detoxified by reaction with 
glutathione (GSH) to form the glutathionyl conjugate, which is further metabolised in the 
kidney to form the N-acetylcysteinyl conjugate, concentrations of which increase with dose 
(Mazaleuskaya et al. 2015). Other extra-hepatic metabolism includes conversion of APAP to 
p-aminophenol (PAP) due to deacetylation by carboxylesterases in kidney, which has been 
observed in e.g., the Fischer rat (Newton et al. 1985) as well as cats and dogs (McConkey et 
al. 2009). PAP formation appears to be a minor route in humans (ca. 1%) and is generally 
followed by rapid re-acetylation (Nicholls et al. 1997). However, little has been reported on 
the metabolism of APAP in the pig, although it has been shown that pigs have a lower 
sulfation capacity than humans (Capel et al. 1972). A known consequence of APAP 
administration to pigs has been the production of methaemoglobin (metHb) and to reduce 
toxicity maintaining serum APAP below 200-300 µg/mL to limit metHb formation has been 
suggested  (He et al. 2017; Newsome et al. 2010; Lee et al 2013: Thiel et al. 2011). Given the 
increasing interest in the use of the pig in preclinical toxicity studies there is a clear need to 
better understand drug metabolism in this species. During the course of the current work on 
the evaluation of efficacy of the UCL-LDD we have taken the opportunity to attempt to better 
define both the metabolic fate of paracetamol and its effects on the endogenous metabolic 
phenotype in this porcine model of hepatotoxicity.   
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4MATERIALS AND METHODS
Chemicals and reagents. Acetaminophen (APAP), its glucuronide (APAP-G) conjugate 
(sodium  salt) and APAP-d3 were purchased from Sigma Aldrich (Gillingham, UK), its 
sulphate (APAP-S)(potassium salt), cysteinyl (APAP-C)(trifluoroacetic acid salt, (TFA)), N-
acetylcysteinyl (APAP-NAC)(disodium salt), glutathione (APAP-SG)(disodium salt) and 3-
methoxy (APAP-OMe) conjugates and the deuterated internal standards, APAP-S-d3 
(potassium salt), APAP-G-d3 (sodium salt), APAP-C-d5 (TFA salt) APAP-NAC-d5 (sodium 
salt) and APAP-SG-d3 (disodium salt), were from Toronto Research Chemicals (Toronto, 
Canada). P-Aminophenol-glucuronide (PAP-G) was from SantaCruz Biotechnology (Dallas, 
Texas, USA). Optima grade water was from Fisher Scientific (Leicester, UK), LC-MS grade 
solvents and formic acid (FA) were from Sigma Aldrich (Poole, UK).
Animal model and study design. The study methodology has been described elsewhere, (Lee 
et al. 2015). Briefly, 22 female Landrace cross Large White Pigs (26-36 kg), between 4 and 6 
weeks of age,  were randomised into 3 groups: APAP plus UCL-LDD (APAP-UCL-LDD; 
n=9), APAP plus Control Device (APAP-CD; n=9) or control plus CD (control-CD; n=4). 
Animals were maintained under total intravenous anaesthesia with intermittent positive 
pressure ventilation and intensive care monitoring and management. To induce ALF, APAP 
(initially 250 mg/kg as an aqueous suspension) was administered via an oroduodenal tube, 
APAP serum concentrations were maintained above 300 mg/L with maintenance APAP 
doses of 0.5-4 g hourly. Dosing continued until the prothrombin time (used as a clinical 
marker of liver dysfunction) as defined by an International Normalised Ratio (INR) 
(Kirkwood, 1983) became >3 at which point the animal was considered to have reach ALF.  
Two hours after onset of ALF, treatment with either the UCL-LDD or a control device (CD) 
was initiated until death. ‘Death’ was defined as non-recoverable cardiorespiratory arrest or 
when two of the following criteria were reached:  haematocrit <10%; blood potassium 
>5.5 mmol/L; blood lactate >10 mmol/L; blood pH <7.25; partial pressure of oxygen in 
arterial blood (PaO2) <60 mmHg. An albumin infusion protocol was developed based on a 
pilot study (Lee et al. 2013). At the onset of APAP dosing 20% human serum albumin was 
infused at 1.6 g albumin/h increasing to 16 g/h at 12h of APAP dosing finally increasing to 
20 g/h at ALF. Control animals were infused with 1.6 g albumin/h throughout the study. 
Albumin infusion was stopped if the serum albumin concentration was greater than 20 g/L. 2 
Units of fresh frozen porcine plasma were given at ALF in both groups. All animals were 
maintained throughout the study with an IV infusion of ‘Viamin 14’ containing a number of 
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5amino acids (Supplementary Information 1). In addition, intravenous fluid therapy to 
support critically ill patients, containing sodium lactate, 0.9% sodium chloride, 8.4% sodium 
bicarbonate, 6% hydroxyethyl starch 130/0.4 and potassium chloride, was administered 
according to set protocols. Serum and plasma sampling was conducted every 4 hours and the 
following parameters were measured in serum: Serum urea (mmol/l), creatinine (µmol/l), 
total bilirubin (µmol/l), AST (U/l), ALP (U/l), Albumin (g/l). Arterial blood gas monitoring 
pre and post ALF included lactate mmol/L and % MetHb and were determined hourly 
(Supplementary Table S1) as was serum paracetamol (mg/l) (see Lee et al 2015). 
Anaesthetic monitor data were taken every 15 minutes, haematology was taken every 4 
hours. Liver biopsies were taken at time 0h, 12h and study endpoint. Kidney samples were 
taken at study endpoint, with histopathology performed on both tissues. Urine samples were 
taken at 4 hour intervals throughout the study. Full methods are provided in previous reports 
(Baker et al. 2015; Lee et al. 2013; Lee et al. 2015). The study design is summarised in 
Supplementary Figure S1. All animal procedures complied with the UK “Animals 
(Scientific Procedures) Act 1986”.
1H-NMR Spectroscopy of Aqueous Tissue Extracts and Urine
1H-NMR spectroscopy of aqueous renal extracts. Kidney extractions for 1H NMR 
spectroscopic analysis were performed as described elsewhere (Beckonert et al. 2007; Want 
et al. 2013). Briefly, 1.5 ml ice-cold methanol/water (1:1, v/v) and kidney tissue (mean 
weight 68.5±6.7 mg) were placed into bead beater tubes. Samples were homogenised using a 
bead beater (Precylls24, Bertin) using two cycles of 6500 Hz for 40 s with samples cooled on 
dry-ice in-between cycles. Samples were then centrifuged at 10,000 g for 10 min (4°C) with 
1ml of supernatant transferred to Eppendorf tubes for concentration in a centrifugal 
evaporator (Eppendorf Concentrator Plus) (45°C overnight). Dried supernatants were 
reconstituted in 580 μL pH 7.4 tissue buffer (Supplementary Information 2) prepared in 
D2O containing  0.5 mM sodium 3-(trimethylsilyl)-[2,2,3,3-2 H4]-propionic acid (TSP), 
vortexed for 90s and centrifuged at 12,000 g for (5 min. 4°C). (This buffer was also used for 
all sample types analysed by 1H NMR spectroscopy). Supernatants (550 μL) were transferred 
to 5 mm NMR tubes (HP-507, Norell) which were inserted into an automated sample 
handling carousel (Bruker Biospin, Germany). 
D
ow
nloaded from
 https://academ
ic.oup.com
/toxsci/advance-article-abstract/doi/10.1093/toxsci/kfaa023/5736567 by guest on 24 February 2020
61H NMR spectroscopy of hepatic aqueous extracts. Liver extracts were prepared using the 
approach used for kidney except that the volume of tissue buffer (Supplementary 
Information 2) was adjusted (20:1, V/W) to the tissue weight (mean 50.6±7.6 mg). 
1H NMR spectroscopy of urine samples. Urine samples were prepared as described elsewhere 
(Dona et al. 2014). Briefly, 600 μL urine was centrifuged at 12,000 g for 5 min at 4°C. 
Supernatants (540 μL) were transferred to 5mm NMR tubes containing urine buffer (60 μL, 
Supplementary Information 2).  1H NMR spectra for urine and tissue extracts were 
acquired on a Bruker Avance-600 spectrometer, using a 4mm BBI probe (Bruker), operating 
at 600.1 MHz 1H frequency and at a temperature of 300 K. A standard one-dimensional 
solvent suppression pulse sequence was used to acquire the free induction decay (FID; 
relaxation delay-90° pulse-4 μs delay-90° pulse-mixing time-90° pulse-acquire FID). The 
D2O and TSP present in the buffer provided a field frequency lock and chemical shift 
reference compound (δ1H = 0.00), respectively. For liver extracts and urine 128 transients 
were collected whilst for kidney extracts the number was increased to 256. The data from all 
of these experiments were collected into 65,000 data points using a spectral width of 12,019.2 
Hz, relaxation delay of 4 s and an acquisition time of 2.73 s. 
1H NMR spectroscopy of plasma samples. Plasma samples were prepared  as described 
elsewhere (Dona et al. 2014).  Spectral data were acquired using a Carr-Purcell-Meiboom-
Gill (CPMG) (Beckonert et al. 2007). 32 Scans were collected into 64 K data points, using a 
spectral width of 12019.23 Hz. Suppression of the water signal was performed during the 
relaxation delay (d1) of 4s, acquisition time was 3.07 s. The D2O present in the buffer 
provided a field frequency lock. 
1H NMR spectral data processing. All 1H NMR spectra were initially processed in TopSpin 
(v3.1, Bruker), where a line-broadening factor of 0.3 Hz was applied prior to Fourier 
transformation (FT). Spectra were automatically phased, baseline-corrected and referenced to 
TSP (δ = 0.00). Using an in-house script, 1H NMR data were imported to MATLAB 
(R2016b, MathWorks). TSP and water resonances were removed, before applying 
probabilistic quotient normalisation for urine and tissue spectra (Dieterle et al. 2006). For 
urine and plasma spectra, peaks were manually aligned using in-house scripts (Veselkov et al. 
2009) before normalisation. Endogenous metabolite assignments were performed using 
Statistical TOtal Correlation Spectroscopy (STOCSY) (Cloarec et al. 2005), J-resolved 
Spectroscopy (JRES), spectral database  and literature (Kyriakides 2016; Merrifield et al. 
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72011; Nicholson et al. 2002). APAP metabolites were assigned using STOCSY, JRES and 
literature (Bales et al. 1988; Gartland et al. 1990; Kyriakides 2016) and standards.
Univariate statistical analysis of 1H NMR data. Prism 8.0 (GraphPad, La Jolla) was used for 
univariate analysis of integrated 1H NMR spectral resonances. Kruskal-Wallis with multiple 
comparison with a FDR multiple test correction (two-stage linear step-up procedure of 
Benjamini, Krieger and Yekutieli) was used to compare between three or more groups and 
Mann-Whitney was used for comparison between two groups. Initially statistical 
comparisons were made between the 3 groups at each time point for Control, APAP+CD and 
APAP + UCL-LDD. As there was no statistical significance between the two device groups 
for any of the metabolites they were combined for further analysis.
UPLC-MS/MS Analysis of Plasma 
Sample Preparation and analysis. Standard curves, QC, and plasma samples were prepared 
as described in Supplementary Information 3, Tables S6-S12 and Figure S10. Briefly, 5 μl 
of plasma were diluted with 85 μl of MeOH and 10 μl of internal standard stock solution 
added. Samples were kept at -20°C for 20 minutes to precipitate proteins, centrifuged (10 
min, 10, 000g) and 20 μL of supernatant diluted with water (980 μL) for analysis.                                                                                       
Chromatography. Analysis was on an Acquity UPLC system using a 2.1 i.d. X 100 mm 
Acquity HSS T3 column packed with a 1.8 µm 130 A C18 stationary phase (Waters 
Corporation) using the run order sequences shown in Supplementary Figure S11. The 
separation was performed at 40°C, The at a flow rate of 0.6 mL/min using a reversed-phase 
gradient, with water: 0.1% (v/v) formic acid (FA) as solvent A and methanol:0.1% (v/v) FA 
as solvent B. The gradient starting conditions were 5% solvent B for 0.5 min, going then, in a 
series of linear gradients to 7%  B (1.85 min) then 8% (1.9 min) 10% (2.5 min), 16% (4.0 
min), 25% (5 min) and finally to 95% (5.1 min) for column washing. The wash solvent 
conditions were maintained at 95% B for 0.9 minutes, returning to the starting conditions by 
6.1 min. With a re-equilibration time of 1.4 min the overall analysis time was 7.5 min/sample. 
(the separation is illustrated in Supplementary Figures S12-13).                                                                 
Mass Spectrometry. MS/MS Data were acquired using a Waters Xevo tandem quadruple 
(TQ)-S mass spectrometer (Waters Corporation, Manchester, UK) operating in positive ion 
electrospray (ESI) mode. MS conditions are given in Supplementary Table S13 (together 
with analyte retention time data). The capillary voltage was set to 3kV, the source 
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8temperature was 150°C, the desolvation temperature was 500°C, and the gas flow 1000 L/h. 
Cone voltages and collision energies were optimised for each compound.
LCMS/MS Data Analysis. Raw LC-MS data were processed by the TargetLynx application 
package within MassLynx software (Waters Corporation). The raw data were mean smoothed 
and peak integration was performed using the ApexTrak algorithm. Concentrations of APAP 
and metabolites were determined by reference to standard curves.
RESULTS
Survival, Histopathological and Biochemical Characterisation of the ALF Model
Following the administration of APAP, ALF was recorded at a median time of 17.5 ± 2.7 h 
(range 12-23 h) with a median total administered dose of 48.5 g (31.5-68.5 g.)  Median 
survival time from ALF for APAP treated animals was 13±3.5 h, with a range from 8-20 h 
(all surviving animals were terminated at 20 h post ALF). Post mortem histopathological 
analysis of liver specimens showed acute centrilobular to midzonal hepatocyte degeneration 
and necrosis in all APAP treated animals, but not in control animals (see Supplementary 
Figure S2). Post mortem histopathological analysis of renal specimens showed tubular 
epithelial cell swelling and protein loss in all APAP-treated animals, but not in control 
animals. At the onset of ALF serum creatinine concentrations were significantly higher in 
APAP-treated animals than the controls, while serum albumin concentrations were 
significantly lower (Figure 1). APAP-treated animals showed hematotoxicity, with 
significantly increased blood concentrations of methaemoglobin and lactate (Figure 1) and 
significant increases in prothrombin time (21±1.3 s at 0h, 80±19 s at ALF). MetHb 
concentrations increased with APAP dosing but decreased upon cessation of dosing at the 
onset of ALF (Figure 1) and were highly variable, ranging from 0.5 % to 13.7 % at that 
point. Intracranial pressure (ICP) increased in APAP treated animals over the course of the 
experiment, while in control animals it remained more constant, although the difference 
between treated and control groups was not statistically significant (Figure 1). ALP, AST 
(which has a high sensitivity for hepatocyte injury in the pig, unlike ALT which does not 
increase significantly in this model, (Lee et al 2013) (Figure 1), bilirubin, and urea 
concentrations were also measured with median and interquartile range for each time point 
provided in Table S1.  
1H NMR Spectroscopy of Tissue Extracts and Biofluids
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9Representative 1H NMR spectra for both liver and kidney tissue extracts and biofluids for 
control and APAP-treated animals  (12h-post APAP administration) are shown in  Figure 2 
whilst Supplementary Figures S3 and 4  show the equivalent results for plasma and urine 
respectively. The 1H NMR spectra from all matrices, but kidney extracts and urine in 
particular, showed convoluted signals between 3 to 4 ppm, from overlapped sugar and amino 
acid resonances, which prevented the integration of peaks in this region. Analysis of the data 
obtained by 1H NMR spectroscopy showed that, there were no statistically significant 
differences between the metabolite profiles of the APAP+CD and APAP + UCL-LDD 
animals, for any of the detected metabolites, and therefore (as indicated in the materials and 
methods) their results were combined.
Plasma 
In the 1H NMR spectra generated from plasma samples 18 endogenous metabolites were 
identified including valine, isobutyrate, alanine, lysine, acetate, pyruvate, glutamine, citrate, 
proline, lactate, glucose, histidine, tyrosine, phenylalanine and formate (Supplementary 
Figures S3 and S5).  In addition overlapped resonances for creatine and creatinine were also 
noted (Supplementary Figures S3 and S5). Following up to 8 h of APAP treatment 
glutamine was significantly decreased in concentration in the plasma of drug-treated animals, 
while tyrosine concentrations were increased. From 16 h post commencement of APAP 
administration the amount of pyruvate detected in plasma was significantly increased in drug 
treated animals whilst plasma glucose and lactate and concentrations both increased 
significantly from the onset of ALF.  Citrate concentrations were increased in APAP-treated 
animals compared to controls from 4 h after the onset of ALF whilst glutamine 
concentrations increased in the latter stages of ALF (Table 1 and Figure S3).
Urine
 In the 1H NMR spectra generated from urine samples (Supplementary Figure S4) 15 
endogenous metabolites were identified (Table 1). During APAP treatment, but prior to the 
onset of ALF, there were significant decreases in the amounts of choline, creatine and 
creatinine with concomitant significant increases in lactate concentration. In APAP-treated 
animals post-ALF, quantities of trimethylamine (TMA) and dimethylamine (DMA) were 
significantly decreased whilst those of glucose were significantly increased compared to 
controls. Urinary alanine concentrations were higher following ALF than in controls 
however, this difference was not statistically significant (Supplementary Figure S6)
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10
Aqueous soluble tissue extracts 
From the spectra of the hepatic extracts (Figure 2)15 endogenous metabolites were identified 
(Table S4). Whilst no significant differences were observed at 0 h or 12 h in post mortem 
samples from the controls those of the APAP-treated animals showed increased quantities of 
succinate, creatine, inosine and isobutyrate (Table 1 and Supplementary Figure S7). There 
was also an increase in the amounts of alanine and lactate in liver extracts from APAP-treated 
animals post-mortem, but these were not statistically significant.  In the 1H NMR spectra of 
kidney extracts (Figure 2) the amounts of total glucose (α and β), succinate and alanine were 
significantly increased in APAP-treated animals compared to controls (Table 1 and 
Supplementary Figure S8). 
Changes in the relative amounts of the various endogenous metabolites detected in biofluids 
or aqueous extracts of  organs are summarised in Table 1. 
APAP metabolism - 1H NMR Spectroscopy
Plasma
APAP, its glucuronide and PAP-G could be detected in the 1H NMR spectra of plasma 
(Supplementary Figure S3), with APAP-G the most abundant, and present at higher 
concentrations than APAP throughout most of the experiment. PAP-G was the only other 
metabolite that could be detected, at lower concentration relative to APAP and APAP-Gat all 
times. 
Urine 
In urine samples APAP and its glucuronide, sulfate, and cysteinyl conjugates, as well as 
PAP-G were detected in the 1H NMR spectra of urine obtained from dosed, but not control 
animals. The major metabolite detected was APAP-G, which was present in the largest 
amounts throughout the experiment, followed by APAP itself, for the first 12 h after the 
commencement of drug administration, after which PAP-G was seen to provide the second 
most abundant APAP metabolite. Both APAP-S and APAP-Cys, were observed in urine 
samples, but at relatively low intensities. (Figure S4)
Tissue Extracts 
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In the renal extracts APAP-G was the most abundant metabolite detected, followed by 
unchanged APAP and APAP-Cys, with PAP-G detected in trace amounts. In the hepatic 
extracts obtained at 12h post the start of drug administration, unchanged APAP had the 
highest abundance, followed by APAP-G and APAP-GSH. PAP-G was also present at low 
intensities (Figure 2 and Supplementary Figure S4). 
Supplementary Tables S2-5 provide details of the 1H NMR spectral data for each of the 
endogenous metabolites as well as APAP and the APAP-metabolites detected in the various 
matrices. 
U(H)PLC-MS/MS of APAP and Metabolites in Plasma 
APAP and its metabolites were quantified by UPLC-MS/MS using stable isotope-labelled 
(SIL) internal standards or, in the case of PAP-G where no SIL was available, monitored and 
semi-quantified relative to an external standard curve. This analysis showed that APAP-G 
was the major APAP-related compound present in the circulation, followed by APAP itself, 
and then PAP-G.  Both APAP-S and APAP-Cys were also detected and quantified but were 
at relatively low concentrations, while APAP-GSH and APAP-NAC were not detected. 
(Figure 3).
DISCUSSION
Paracetamol-induced changes in endogenous metabolite profiles
There were endogenous changes in metabolism which indicated effects on 3 main pathways; 
energy metabolism, amino acid metabolism and choline metabolism. Similar changes have 
been reported  previously in APAP induced ALF with e.g., increased concentrations of a 
number of components of the citric acid cycle, such as succinate (Coen et al. 2003; Coen et 
al. 2004; Dabos et al. 2011; Kyriakides 2016). In the current model there were also increased 
concentrations of citrate and this, coupled with the pre-ALF increase in circulating lactate, 
pyruvate and alanine in plasma indicates that there was a hepatic switch to glycolysis early on 
after APAP treatment due to mitochondrial dysfunction (see Figure 4). In accordance with 
previous animals models, but contrary to the report by Dabos et al., we also detected an 
increase in glucose in the kidney, suggesting gluconeogenesis was upregulated in the kidney 
to compensate for the reduction in hepatic energy metabolism (Dabos et al. 2011). 
Changes to the circulating glutamine concentrations resemble the glutamine increase seen in 
human ALF, and this change has been proposed to be linked to hepatic encephalopathy (Rao 
D
ow
nloaded from
 https://academ
ic.oup.com
/toxsci/advance-article-abstract/doi/10.1093/toxsci/kfaa023/5736567 by guest on 24 February 2020
12
et al. 2012). The upregulation of glutamine (Holecek 2014) and urinary decreases in TMA, 
DMA and TMAO concentrations in APAP treated animals may show alteration to gut 
microbiota (Ussher et al. 2013). Changes to creatine and creatinine in the cirulation, urine and 
liver have also been previously seen in APAP toxicity and DILI (Kyriakides 2016) with an 
increase in the amounts in the circulation, and decreases in urine, commonly indicative of 
poor renal clearance. There was also a significant decrease in hepatic inosine concentrations. 
This may be significant with respect  to the methaemoglobinaemia as porcine erythrocytes 
use hepatically-derived inosine as a substitute for glucose for glucose (Watts et al. 1979) and 
inosine has been shown, in vitro, that inosine is used to efficiently generate NADH for the 
enzymatic reduction of methaemoglobin in pig erythrocytes (Sartorelli et al. 1996). 
 APAP metabolism & its relation to toxicity in the pig
Glucuronidation predominated over sulfation in the metabolism of APAP in the pig with the 
latter appearing to represent only a minor reaction with low concentrations of the sulfate 
conjugate detected in urine and the circulation. Similar results were seen for the metabolism 
of p-cresol (a phenol with structural and metabolic similarities to APAP) (Merrifield et al. 
2011; Thorn et al. 2012).  These results are consistent with the pig having been shown to 
have a reduced sulfation capacity compared to human (Capel et al. 1972).  Interestingly, the 
second most abundant metabolite  measured in plasma and urine was PAP-G, which we 
propose to haveen formed by the glucuronidation of PAP (Figure 5) following the N-
deactylation of APAP. That PAP-G  was formed to a greater extent in the pig than in other 
species was presumably due to differences in the key drug metabolising enzymes responsible 
for both the de- and re-acetylation of aromatic amides and amines such as APAP and PAP in 
this species. The production of PAP provides a ready explanation for the  methaemoglobin 
and nephro-toxicity observed in pigs  dosed with APAP. Previously it has been  suggested 
that the production of methaemoglobin in pigs administered APAP was the result of 
erythrocyte GSH depletion and poor glucose uptake (Hennebruns et al. 1988; Newsome et al. 
2010).  However, the well known association of aromatic amines, including PAP, with 
methaemoglobin formation (Harrison and Jollow 1987) provides a more obvious mechanism. 
Indeed,  PAP has previously been suggested as the cause of APAP induced 
methaemoglobinemia cats and dogs (McConkey et al. 2009). In most species, N-acetylation 
reactions in the liver are catalysed by N-acetyl transferase (NAT) enzymes NAT1 and NAT2, 
while de-acetylation is catalysed by carboxylesterases (CES) including CES1 and CES2 and 
arylacetamide deacetylase (AADAC) in human. The rates of these de annd re-acetylation 
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reactions have been shown to vary significantly amongst species (Jones et al. 2016; 
McConkey et al. 2009; Watanabe et al. 2010). APAP has been shown to form PAP by N-
deacetylation in man as a minor route of metabolism, and to a greater extent in rat with, in 
both cases, the majority being detoxified by rapid re-acetylation to APAP in a so called 
‘futile-deacetylation’ reaction (Nicholls et al. 1995).  The formation of methaemoglobin in 
the dog is attributed to a lack of either NAT1 or NAT2 enzymes and in cats to be the result of 
their only expressing NAT1 (McConkey et al. 2009). C57BL6 mice have been shown to be 
slow to deacetylate APAP, but rapid to re-acetylate and, whilst methaemoglobin was formed 
as a result of  APAP administration to NAT1/2 knockout mice, it was not comparable to the 
levels seen in dogs or cats. In addition to methaemoglobinemia APAP administration to pigs 
in this study was associated with nephrotoxicity and the production of PAP represents a 
possible cause of this. For example, in rats, PAP has been reported to be a potent nephrotoxin 
(C. R. Green 1969 ; Gartland et al. 1990), primarily effecting the proximal tubules (Fowler et 
al. 1993; Fowler et al. 1994; Yang et al. 2007), causing both tubular dilation and necrosis. 
Similar pathological changes were observed in this study for the pig. The exact mechanism of 
PAP-induced nephrotoxicity is not fully understood, however it has been postulated that the 
mechanism involves formation of PAP-glutathionyl conjugate as PAP-GSH has been 
reported to be more nephrotoxic than PAP itself (Fowler et al. 1993; Fowler et al. 1991). 
Furthermore, PAP-GSH-induced nephrotoxicity has been reported to lead to glycosuria, 
which could explain the observed increase to  glucose concentrations in the urine seen in the 
current work (Fowler et al. 1991). γ-Glutamyltransferase (GGT)  is predominantly localised 
in the brush border membrane of renal proximal tubules, the area susceptible to PAP and 
PAP-GSH mediated nephrotoxicity. The inhibition of GGT has been reported to be protective 
against PAP-GSH mediated nephrotoxicity (Fowler et al. 1994). Studies utilising suitably 
labelled APAP in the acetyl moiety (e.g. see Nicholls et al. 1995, 1997) would be required to 
confirm the extent, if any, of futile deacetylation in the porcine model.  
Despite clear ALF in these animals the relatively low amounts of GSH-derived APAP 
metabolites detected suggest, that this is not a major route in the pig. This is based, in part, on 
similar studies on mouse liver after APAP administration, where concentrations of APAP-
GSH in aqueous extracts were comparable to those of APAG (Kyriades et al 2016). However, 
the low concentrations of APAP-GSH detected in pig liver extracts, plasma and urine may 
conceivably result from other factors such as e.g., rapid and extensive biliary excretion etc. 
However, it is clear from recent in vitro studies, in e.g. HepG2 cells which are deficient in 
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CYP450 activity, that APAP can also act as CYP metabolism-independent cytotoxin 
(Behrends et al 2019).This type of toxicity was linked to “a decoupling of glycolysis from the 
TCA cycle, lactic acidosis, reduced NADPH production and subsequent suppression of the 
anabolic pathways required for rapid growth” (Behrends et al 2019), providing a mechanism 
for cell death that is independent of oxidative stress. The clear  hepatotoxicity observed here 
and in previous studies in the pig following APAP administration may therefore be the result 
of a combination of the effects of the production of reactive metabolites via NAPQI and 
direct cytotoxicity as seen in HepG2 cells.  With respect to the study of human-relavant 
hepatotoxicy of APAP the mouse is  perhaps the most appropriate model (Jaeschke et al 
2014).  However, the species differences in drug metabolism highlighted here for the pig go 
beyond those of the biotransformation of APAP and may significantly affect the toxicity 
profile of other drugs and xenobiotics with siimilar structural features. 
CONCLUSIONS
The pig is susceptible to hepatotoxicity, renal toxicity and MetHb in response to paracetamol 
administration. The paracetamol-induced hepatotoxicity in the pig shows some 
histopathological similarity to that seen in humans, with a number of clinical similarites to 
APAP-induced ALF including signs of hepatic encephalopathy. In addition to hepatic 
toxicity, some renal toxicity was identified which may be related to the formation of PAP, as 
evidenced by relatively high concentrations of PAP-G in the liver, kidney, plasma and urine 
of these animals. The pig showed low sulfation of APAP, producing mainly the phenolic  
glucuronide. In addition deacetylation to PAP, which was combined with formation of PAP-
glucuronide and methaemoglobinemia was observed. Only small amounts of the NAPQI-
derived glutathione-related metabolites were detected. The metabolic differences observed 
here may mean that  the pig represents a poor model for translational toxicty studies for 
humans for compounds undergoing high levels of  sulfation. Similar concerns may also apply 
to studies with compounds that contain amide bonds which, if hydrolysed, would lead to 
toxicity.  The pig  may however, be  useful model where amide hydrolysis is seen for drugs 
or environmental chemicals in humans, but not in e.g., rat  and dog.
SUPPLEMENTARY DATA
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Figure Captions
Figure 1. Parameters measured to characterise the ALF model. Each is plotted at 4 h 
intervals up to ALF, and thereafter at 4 hourly intervals to post mortem. The figure shows, 
from left to right, upper row; albumin, creatinine and AST.  Middle row; ALP, blood lactate 
and blood % metHb and bottom row; intracranial pressure (ICP) measured via anaesthetic 
monitoring.  Boxes display median and inter-quartile range and the whiskers show the full 
range. Asterisk (*) indicates where APAP-treated animals were significantly different to 
controls with a q value <0.05 after FDR correction, following Kruskal-Wallis with multiple 
comparisons
Figure 2. Representative 1H NMR spectra of porcine liver (UPPER) (at ALF in an APAP 
treated and a Control animal at 20 h) and kidney (LOWER) at post mortem with key 
endogenous and drug metabolite resonances labelled.
Figure 3. Metabolites quantified in plasma using UHPLC-MS/MS up to, and post animal-
dependent ALF.
Figure 4. Diagram showing the key components of the TCA cycle within the mitochondria 
seen to change in one or more of the matrices and biofluids investigated. The TCA cycle 
components have been colour coded to show in which of the matrices these compentents 
were increased (as per key within figure) in the samples following the onset of ALF.
Figure 5. APAP metabolism in the pig showing the formation of PAP, PAP-derived metHb, 
PAP-G and the putative nephrotoxin PAP-GSH.
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Table 1. Summary of endogenous metabolite changes in APAP-treated pigs relative to                                                                                                                                                
controls across all matrices at the pre-ALF and Post ALF timepoints*.
Sample 
Matrix
Metabolite 
Changes Pre-ALF
P value Adjusted p 
value (q)
Metabolite 
Changes Post-ALF
P value Adjusted p 
value (q)
Pyruvate 0.0001 0.0002 Pyruvate 0.0005 0.0006
Lactate 0.002 0.0012 Lactate <0.0001 0.0002
Glucose 0.0172 0.009 Glucose <0.0001 <0.0001
Glutamine 0.0002 0.0007 Glutamine 0.0018 0.0037
Tyrosine <0.0001 0.0002 Alanine 0.0047 0.308
Plasma
Citrate <0.0001 0.0002
Dimethylamine 0.0637 0.0418 Dimethylamine 0.0012 0.0046
Trimethylamine <0.0001 0.0001 Trimethylamine <0.0001 0.0001
Choline 0.0025 0.0286 Glucose <0.0001 0.0004
Creatine 0.0003 0.0011 Creatine 0.0075 0.0073
Creatinine 0.0006 0.0068
Urine
Lactate 0.0001 0.0012
Creatine <0.0001 <0.0001
Isobutyrate 0.0117 0.0245
Succinate <0.0001 <0.0001
Inosine 0.0088 0.0184
Alanine† 0.0236 0.0743
Liver No significant changes
Lactate† 0.224 0.706
Glucose 0.0003
Succinate 0.0074
Kidney No Data
Alanine 0.0104
Not 
Applicable
Red=metabolite increase Blue=Metabolite decrease †=changes not statistically significant
*ALF occurred at 17.5 ± 2.7 h post onset of APAP treatment.  Pre-ALF refers to all time points prior to ALF 
and post-ALF to all time points after ALF. 
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 Figure 1. Parameters measured to characterise the ALF model. Each is plotted at 4 h 
intervals up to ALF, and thereafter at 4 hourly intervals to post mortem. The figure shows, 
from left to right, upper row; albumin, creatinine and AST. Middle row; ALP, blood lactate 
and blood % metHb and bottom row; intracranial pressure (ICP) measured via anaesthetic 
monitoring. Boxes display median and inter-quartile range and the whiskers show the full 
range. Asterisk (*) indicates where APAP-treated animals were significantly different to 
controls with a q value <0.05 after FDR correction, following Kruskal-Wallis with multiple 
comparisons 
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 Figure 2A. Representative 1H NMR spectra of porcine liver (UPPER) (at ALF in an APAP 
treated and a Control animal at 20 h) and kidney (LOWER) at post mortem with key 
endogenous and drug metabolite resonances labelled. 
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 Figure 2B. Representative 1H NMR spectra of porcine liver (UPPER) (at ALF in an APAP 
treated and a Control animal at 20 h) and kidney (LOWER) at post mortem with key 
endogenous and drug metabolite resonances labelled. 
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 Figure 3. Metabolites quantified in plasma using UHPLC-MS/MS up to, and post animal-dependent ALF. 
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 Figure 4. Diagram showing the key components of the TCA cycle within the mitochondria 
seen to change in one or more of the matrices and biofluids investigated. The TCA cycle 
components have been colour coded to show in which of the matrices these compentents 
were increased (as per key within figure) in the samples following the onset of ALF. 
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 Figure 5. APAP metabolism in the pig showing the formation of PAP, PAP-derived metHb, PAP-G and the 
putative nephrotoxin PAP-GSH. 
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